Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful catheter ablation for atrial fibrillation
Heart and Vessels · 2024-08 · 39 (8) · 706-713
DOI: 10.1007/s00380-024-02385-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart and Vessels, online erschienen am 06.03.2024. Verfasst von Aiko Takami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, 36-1 Nishi-Cho, Yonago, 683-8504, Ja…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Adrenergic beta-Antagonists, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Tachycardia induces a reduction in the left ventricular ejection fraction (LVEF), which is defined as tachycardia-induced cardiomyopathy (TIC). Conversion to and maintenance of sinus rhythm by catheter ablation can improve LVEF in patients with TIC due to atrial fibrillation (AF). Beta-blockers are mandatory for the treatment of heart failure with reduced LVEF(HFrEF), but the necessity of beta-blockers in TIC patients even after catheter ablation remains unclear. We examined the effect of beta-blockers on cardiac function in TIC patients after catheter ablation. We retrospectively analyzed 124 patients with a history of heart failure and an LVEF of ≤ 50% who underwent catheter ablation for AF. TIC was defined as a ≥ 10% improvement in the baseline LVEF and an improvement to an LVEF of ≥ 50% at 6 months after ablation. Patients with other cardiomyopathy diagnosed before the ablation were excluded. LVEF was significantly increased with the reductions of the left ventricular and left atrial volumes at the 6-month follow-up in all 80 patients with TIC. No beta-blockers were prescribed during the post-ablation follow-up in 21 patients with TIC. The absolute values of and changes in the echocardiographic parameters between before and after ablation were not significantly different between patients with and without beta-blockers after the ablation. A simple score using the history of hospitalization for heart failure and use of beta-blockers or diuretics prior to ablation was useful in identifying TIC patients who did not need prescription of beta-blockers after catheter ablation. LVEF similarly improved in both patients with and without prescription of beta-blockers after the ablation. Beta-blockers may not need to be prescribed after successful catheter ablation for AF in LVEF of ≤ 50% patients without other cause of cardiomyopathy diagnosed before the ablation, a history of hospitalization for heart failure and prescription of beta-blockers and diuretics before the ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, 36-1 Nishi-Cho, Yonago, 683-8504, Japan.
- Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, 36-1 Nishi-Cho, Yonago, 683-8504, Japan. kato3@tottori-u.ac.jp.
Zitieren
APA
Takami, A., Kato, M., Kotake, Y., Okamura, A., Tomomori, T., Kawatani, S., & Yamamoto, K. (2024). Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful catheter ablation for atrial fibrillation. Heart and Vessels, 39(8), 706-713. https://doi.org/10.1007/s00380-024-02385-7
Vancouver
Takami A, Kato M, Kotake Y, Okamura A, Tomomori T, Kawatani S, et al. Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful catheter ablation for atrial fibrillation. Heart and Vessels. 2024;39(8):706-713. doi:10.1007/s00380-024-02385-7
BibTeX
@article{Takami2024,
author = {Takami, Aiko and Kato, Masaru and Kotake, Yasuhito and Okamura, Akihiro and Tomomori, Takuya and Kawatani, Shunsuke and Yamamoto, Kazuhiro},
title = {Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful catheter ablation for atrial fibrillation},
journal = {Heart and Vessels},
year = {2024},
volume = {39},
number = {8},
pages = {706--713},
doi = {10.1007/s00380-024-02385-7}
}
EUVIMED